Clinical & translational oncology

• 

  Año 2017, Vol. 19, Número 2 (February 2017)

  • Special Article

    • SEOM/SERAM consensus statement on radiological diagnosis, response assessment and follow-up in colorectal cancer

      Rocío García Carbonero, Ruth Vera García, Fernando Rivera Herrero, Elena Parlorio de Andrés, Mario Pagès, Encarnación González Flores, Carlos Fernández Martos, Miguel Ángel Corral de la Calle, R. Bouzas, Fátima Matute Teresa

      • Resumen

      págs. 135-148

      

  • Clinical Guides in Oncology

    • Defining the optimal sequence for the systemic treatment of metastatic breast cancer

      Joan Albanell Mestres, Agustí Barnadas i Molins, Lourdes Calvo Martínez, José Ignacio Chacón López Muñiz, Eva Ciruelos, Ana de Juan Ferré, Sonia del Barco Berrón, Y. F. Pérez, Jesús García Mata, Andrés García Palomo, Joaquín Gavilá Gregori, P. G. Pardo, José Juan Illarramendi Mañas, Ana Lluch Hernández, Eduardo Martínez de Dueñas, N. Martínez Jáñez, S. Morales Murillo, Javier Salvador Bofill, P. Zamora Auñon, Pedro Sánchez Rovira

      • Resumen

      págs. 149-161

      

  • Research Article

    • Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression

      C.-Y. Li, G.-Y. Liang, W.-Z. Yao, J. Sui, X. Shen, Y.-Q. Zhang, H. Peng, W.-W. Hong, Y.-C. Ye, Z.-Y. Zhang, W.-H. Zhang, L.-H. Yin, Y.-P. Pu

      • Resumen

      págs. 162-172

      

    • Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience

      Emmanuelle Kempf, G. Desamericq, Begoña Vieites Pérez-Quintela, Iván Díaz Padilla, E. Calvo, Purificación Estévez García, Aida García Arreza, María Angeles Martínez Maestre, Ignacio Durán Martínez

      • Resumen

      págs. 173-179

      

    • Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial

      Kevin M. Kalinsky, T. Zheng, H. Hibshoosh, X. Du, P. Mundi, J. Yang, S. Refice, S. M. Feldman, B. Taback, E. Connolly, K. D. Crew, M. A. Maurer, Dawn Hershman

      • Resumen

      págs. 180-188

      

    • Radiation dose intensification in pre-operative chemo-radiotherapy for locally advanced rectal cancer

      F. Alongi, S. Fersino, R. Mazzola, A. Fiorentino, N. Giaj Levra, F. Ricchetti, R. Ruggieri, G. Di Paola, M. Cirillo, S. Gori, M. Salgarello, G. Zamboni, G. Ruffo

      • Resumen

      págs. 189-196

      

    • Impact of HER2 expression on outcome in gastric cancer patients with liver metastasis

      H. Jiang, Q. Li, S. Yu, Y. Yu, Y. Wang, W. Li, Y. Cui, T. Liu

      • Resumen

      págs. 197-203

      

    • Demand for radiotherapy in Spain

      Aurora Rodríguez Pérez, Josep Maria Borràs Andrés, José López Torrecilla, Manuel Ignacio Algara López, Amalia Palacios Eito, Antonio Gómez Caamaño, Luis Olay Gayoso, Pedro Lara Jiménez

      • Resumen

      págs. 204-210

      

    • Multiparametric evaluation of preoperative MRI in early stage breast cancer: prognostic impact of peri-tumoral fat

      J.-P. Obeid, R. Stoyanova, D. Kwon, M. Patel, K. Padgett, J. Slingerland, C. Takita, N. Alperin, M. Yepes, Y. H. Zeidan

      • Resumen

      págs. 211-218

      

    • Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

      Javier de Castro Carpeño, José Luis González Larriba, Sergio Vázquez Estévez, Bartomeu Massuti Sureda, José Miguel Sánchez Torres, Manuel Dómine Gómez, María Pilar Garrido López, Antonio Calles, Ángel Artal Cortés, Ricardo Collado Martín, María Rosario García Campelo, M. Sereno Moyano, Margarita Majem, José Antonio Macías Cerrolaza, Óscar Juan Vidal, José Gómez Codina, Berta Hernández Marín, Martin Lázaro Quintela, A. L. Ortega Granados, Manuel Cobo Dols, José Manuel Trigo Pérez, Enric Carcereny Costa, C. Rolfo, S. Maciá Escalante, José Muñoz Langa, Pilar Diz Taín, Miguel Méndez Ureña, F. E. Rosillo Fernández, Luis Paz-Ares Rodríguez, J. V. Cardona, Dolores Isla Casado

      • Resumen

      págs. 219-226

      

    • Efficacy of trifluridine and tipiracil (TAS-102) versus placebo, with supportive care, in a randomized, controlled trial of patients with metastatic colorectal cancer from Spain: results of a subgroup analysis of the phase 3 RECOURSE trial

      Federico Longo Muñoz, Guillem Argilés Martínez, Josep Tabernero Caturla, Andrés Cervantes Ruiperez, Cristina Grávalos Castro, Carles Pericay Pijaume, S. Gil Calle, H. Mizuguchi, Alfredo Carrato Mena, M. L. Limón Mirón, Rocío García Carbonero

      • Resumen

      págs. 227-235

      

    • Chronic opioid therapy in long-term cancer survivors

      Alberto Carmona Bayonas, P. Jiménez Fonseca, Eduardo Castañón, Avi Ramchandani Vaswani, Rodrigo Sánchez Bayona, Ana Custodio, David Calvo Temprano, Juan Antonio Virizuela Echaburu

      • Resumen

      págs. 236-250

      

    • Advanced breast cancer clinical nursing curriculum: review and recommendations

      Concepción Vila Borrajo, Concepción Reñones Crespo, Társila Ferro, María Ángeles Peñuelas Huertas, María del Mar Jiménez Abad, Álvaro Rodríguez Lescure, Montserrat Muñoz, Ramón Colomer Bosch

      • Resumen

      págs. 251-260

      

  • Brief Research Article

    • Is mucin a determinant of peritoneal dissemination of gastrointestinal cancer?: Analysis of mucin depletion in two preclinical models

      S. Masoumi-Moghaddam, A. Amini, D. L. Morris

      • Resumen

      págs. 261-264

      

    • FGFR2 overexpression predicts survival outcome in patients with metastatic papillary renal cell carcinoma

      I. Tsimafeyeu, A. Khasanova, E. Stepanova, M. Gordiev, D. Khochenkov, A. Naumova, I. Varlamov, A. Snegovoy, L. Demidov

      • Resumen

      págs. 265-268